Cantor Fitzgerald Reaffirms Overweight Rating for SI-BONE (NASDAQ:SIBN)

Cantor Fitzgerald restated their overweight rating on shares of SI-BONE (NASDAQ:SIBN – Free Report) in a research report released on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $30.00 price target on the stock. Several other equities analysts have also recently issued reports on the company. Needham & Company LLC reissued a buy rating and […]

Related Keywords

United States ,America ,Jeryll Hilleman ,Anthonyj Recupero , ,Needham Company ,Company Profile ,Voya Investment Management ,Nasdaq ,Pricet Rowe Associates Inc ,Securities Exchange Commission ,Kent Lake Capital ,Cantor Fitzgerald ,Free Report ,Truist Financial ,Director Jeryl ,Exchange Commission ,Investment Management ,Lake Capital ,Get Free Report ,Si Bone ,Nasdaq Sibn ,Sibn ,Medical ,Reiterated Rating ,